Acadia Healthcare EPS - Earnings per Share 2010-2024 | ACHC
Acadia Healthcare eps - earnings per share from 2010 to 2024. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
Acadia Healthcare Annual EPS |
2023 |
$-0.24 |
2022 |
$2.98 |
2021 |
$2.10 |
2020 |
$-7.59 |
2019 |
$1.24 |
2018 |
$-2.01 |
2017 |
$2.30 |
2016 |
$0.07 |
2015 |
$1.64 |
2014 |
$1.50 |
2013 |
$0.85 |
2012 |
$0.53 |
2011 |
$-1.86 |
2010 |
$0.35 |
2009 |
$0.16 |
Acadia Healthcare Quarterly EPS |
2024-09-30 |
$0.74 |
2024-06-30 |
$0.85 |
2024-03-31 |
$0.83 |
2023-12-31 |
$0.64 |
2023-09-30 |
$-2.39 |
2023-06-30 |
$0.79 |
2023-03-31 |
$0.72 |
2022-12-31 |
$0.65 |
2022-09-30 |
$0.78 |
2022-06-30 |
$0.88 |
2022-03-31 |
$0.67 |
2021-12-31 |
$0.77 |
2021-09-30 |
$0.73 |
2021-06-30 |
$0.49 |
2021-03-31 |
$0.11 |
2020-12-31 |
$-8.78 |
2020-09-30 |
$0.42 |
2020-06-30 |
$0.46 |
2020-03-31 |
$0.38 |
2019-12-31 |
$-0.13 |
2019-09-30 |
$0.48 |
2019-06-30 |
$0.55 |
2019-03-31 |
$0.34 |
2018-12-31 |
$-3.79 |
2018-09-30 |
$0.53 |
2018-06-30 |
$0.67 |
2018-03-31 |
$0.58 |
2017-12-31 |
$0.81 |
2017-09-30 |
$0.52 |
2017-06-30 |
$0.57 |
2017-03-31 |
$0.40 |
2016-12-31 |
$0.47 |
2016-09-30 |
$-1.36 |
2016-06-30 |
$0.65 |
2016-03-31 |
$0.31 |
2015-12-31 |
$0.50 |
2015-09-30 |
$0.42 |
2015-06-30 |
$0.49 |
2015-03-31 |
$0.23 |
2014-12-31 |
$0.38 |
2014-09-30 |
$0.43 |
2014-06-30 |
$0.43 |
2014-03-31 |
$0.26 |
2013-12-31 |
$0.25 |
2013-09-30 |
$0.29 |
2013-06-30 |
$0.24 |
2013-03-31 |
$0.07 |
2012-12-31 |
$0.11 |
2012-09-30 |
$0.15 |
2012-06-30 |
$0.16 |
2012-03-31 |
$0.11 |
2011-12-31 |
$-0.79 |
2011-09-30 |
$0.18 |
2011-06-30 |
$-1.24 |
2011-03-31 |
$-0.01 |
2010-12-31 |
$0.00 |
2010-09-30 |
$0.09 |
2009-12-31 |
$0.00 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical - Hospitals |
$3.584B |
$2.929B |
Acadia Healthcare Company, Inc. provides behavioral health care services in the United States. The U.S. segment comprises acute inpatient psychiatric facilities, specialty treatment facilities, residential treatment centers, outpatient community-based services, wholly-owned facility, and also comprehensive treatment centers (CTCs). For the services rendered in its facilities, the company receives payments from (i) state governments under their respective Medicaid and other programs; (ii) commercial insurers; (iii) the federal government under the Medicare program administered by CMS; (iv) public funded sources in the U.K.; and (v) individual patients and clients.
|